Download presentation
Presentation is loading. Please wait.
Published byStella Singletary Modified over 9 years ago
1
Jason E. Davis, MD PERI-OPERATIVE CARDIAC RISK REDUCTION, A-FIB/MI MANAGEMENT
2
~27 million non-cardiac surgeries per year 1 – 1.5 million for pt’s w/ known cardiac disease 3 – 4 million for pt’s with 3 or more risk factors for coronary artery disease (DM, smoking, etc) Past 50 years in surgery Dramatic changes in procedures Improvements to survival SURGERY AS A CONTROLLED INJURY
3
Predictable responses Body doesn’t differentiate surgery from injury Fight or flight, mobilization of energy stores “Physiological Narrowing” 20 years old and healthy generally tolerates stressors better than pt 80 years old Graded neuro-endocrine response Bigger surgery, bigger response SURGERY AS A CONTROLLED INJURY
4
Anterior Pituitary – ACTH – Growth hormone – Prolactin – Endorphin Posterior Pituitary – Arginine vasopressin Adrenals – Cortisol – Epinephrine (rises until 3 hrs) – Norepinephrine (until 3 days) PREDICTABLE RESPONSES
5
Analgesia Hypercoagulability (control of blood loss) Mobilization of metabolic substrates (glucose) Conservation of fluid, electrolytes POST-INJURY/SURGERY DEFENSES
6
Altered hemodynamics – Hypertension – Fluid and metabolite shifts – Tachycardia – Hypercoagulability – DVT, pulmonary embolus – Myocardial Ischemia – Congestive heart failure – Tachyarrhythmia Hypokalemia Hypomagnesemia Immune suppression Infectious complications Hyperglycemia CONSEQUENCES & COMPLICATIONS
7
Defining overall risk PMH = Opportunity to Prevent, Plan, Adapt Highest risk for complications First 3 days post-operatively Corresponds to injury + response SEQUENCE OF EVENTS
8
American Society of Anesthesiologists risk stratification and classification scheme Class 1: Normal healthy patient Class 2: Patient with mild systemic disease Class 3: Severe systemic disease, limits function Class 4: Incapacitating, constant threat to life Class 5: Moribund, unlikely to survive +/- surgery Class 6: Brain-dead organ donor PATIENT SELECTION
9
American Society of Anesthesiologists risk stratification and classification scheme Class 1: Mortality 0 – 2% Class 2: Mortality 0.5 – 3% Class 3: Mortality 5 – 10% Class 4: Mortality 75% Elective vs. Emergent: 2 – 3x risk Also: Magnitude, Duration… PATIENT SELECTION
10
High Risk factors Acute/recent MI Unstable coronary dx De-compensated CHF Significant arrhythmias Severe valvular disease EAGLE’S CARDIAC RISK ASSESSMENT HTTP://WWW.FPNOTEBOOK.COM/CV/SURGERY/EGLSCRDCRSKASMNT.HTM
11
Intermediate Risk factors Mild angina History of MI, compensated CHF Renal insufficiency, DM Minor Risk Factors Advanced age Abnormal EKG Low functional capacity EAGLE’S CARDIAC RISK ASSESSMENT HTTP://WWW.FPNOTEBOOK.COM/CV/SURGERY/EGLSCRDCRSKASMNT.HTM
12
Eagle’s cardiac risk assessment – >70 years age – History of angina – History of ventricular dysfunction – Diabetes on therapy – Abnormal Q-waves on EKG ACC-AHA Criteria – Functional Capacity (I – IV) – Graded by “Metabolic Equivalents” (>4 METS = lower risk) Detsky’s Modified risk index Goldman criteria FURTHER PRE-OP PLANNING HTTP://WWW.FPNOTEBOOK.COM/CV/SURGERY/ACAHPRPRTVCRDCRSKAS MNT.HTM
13
Beta-Blockers – Chronic users (AM w/ sip of water) – High risk non-users prescribed pre-op Remember neuro-endocrine response Anticoagulants – soon as outweighs bleeding – Coumadin Interim heparin – Aspirin, Plavix Statins – mixed literature CONTINUATION OF MEDICATIONS
14
Pre-operative – Pre-emptive anesthesia (local, systemic) – Appreciate pt’s entire risk -- not just surgical! Intra-operative – Product of underlying problems x surgical stress Post-operative – Pain control – Fluid balance, early mobilization – Tx co-morbid conditions ATTENUATION OF STRESS RESPONSE
15
Anesthetic selection – Local +/- sedation – Regional (epidural, spinal, etc) – General Temperature control – National initiatives to 37C Improved bloodflow Decreased neuro-endocrine ANESTHETIC FACTORS (COLLABORATIVELY ADDRESSED WITH ANESTHESIA COLLEAGUES)
16
Recognition – Irreg rhythm, tachycardia +/- CP, SOB, hypotension Diagnosis – EKG, new onset often secondary to ischemia Treatments – Attempt to normalize B-blocker > Diltiazem > Digoxin – Rate control (often same meds) – Anticoagulation soon as poss Prevent propagation thrombus ATRIAL FIBRILLATION
17
Recognition Tachycardia, hypotension, chest pain, new onset a-fib, shortness of breath, mental status change Diagnosis EKG, Troponin/CKMb, CXR (assess alt causes) Treatment B-blocker, nitrates, heparin, morphine, asa, statins Cardiology consult PRN MYOCARDIAL ISCHEMIA
18
Lehigh Valley Heart Specialists Nurse available on-call Contact: Lehigh Valley Heart Care Group Fellow available on-call Contact: LVHN CARDIOLOGY CONSULTS
19
Consider whole pt Surgery (controlled injury) + co-morbidities Risk reduction Pt stratification Clearance, medications Coordination of care MI: dx, decrease work, decrease pain, +O2 A-fib: ‘break’, rate, anticoag. SUMMARY
20
THANK YOU.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.